Revenue Growth Track RecordA multi-year pattern of rising revenue provides a durable foundation for future cash generation and investment. Sustained top-line growth reflects expanding patient volumes or service mix in core care facilities, reducing execution risk and supporting reinvestment in capacity and quality over the next 2–6 months and beyond.

High And Improving MarginsConsistently strong gross and operating margins indicate structural cost discipline and pricing power in the business model. Robust EBIT/EBITDA margins support sustainable free cash flow generation, which strengthens funding for capex and debt servicing, and offers resilience to industry cost swings.

Solid Balance SheetA strong equity base and prudent leverage give the company financial flexibility to fund expansion, absorb shocks, and maintain operations without immediate refinancing needs. This stability supports strategic investments and lowers default risk over the medium term.

Bears Say

Material Capital ExpendituresSustained high capex pressures free cash flow despite improving operating cash generation. Over a 2–6 month horizon, continued heavy investment can constrain discretionary spending, increase reliance on external financing, and limit the speed at which cash reserves can be redeployed to other strategic priorities.

Recent EBIT PressureAn observable decline in EBIT signals potential operational or cost headwinds that could persist without corrective action. If margin pressure continues, it may erode profitability and reduce the conversion of revenue into sustainable operating cash flow over the medium term.

Execution DependenceThe company's outlook relies on effective management of operations and disciplined capex. Execution shortfalls—on cost control, integration of capacity, or project timing—could derail revenue-to-profit conversion and weaken liquidity, making performance sensitive to management execution over the coming months.

LIK FAQ

What was Limes Schlosskliniken AG’s price range in the past 12 months?

Limes Schlosskliniken AG lowest stock price was €250.00 and its highest was €500.00 in the past 12 months.

What is Limes Schlosskliniken AG’s market cap?

Limes Schlosskliniken AG’s market cap is €144.60M.

When is Limes Schlosskliniken AG’s upcoming earnings report date?

Limes Schlosskliniken AG’s upcoming earnings report date is May 19, 2026 which is in 91 days.

How were Limes Schlosskliniken AG’s earnings last quarter?

Limes Schlosskliniken AG released its earnings results on Sep 01, 2025. The company reported €11.301 earnings per share for the quarter, beating the consensus estimate of N/A by €11.301.

Is Limes Schlosskliniken AG overvalued?

According to Wall Street analysts Limes Schlosskliniken AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Limes Schlosskliniken AG pay dividends?

Limes Schlosskliniken AG does not currently pay dividends.

What is Limes Schlosskliniken AG’s EPS estimate?

Limes Schlosskliniken AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Limes Schlosskliniken AG have?

Limes Schlosskliniken AG has 300,000 shares outstanding.

What happened to Limes Schlosskliniken AG’s price movement after its last earnings report?

Limes Schlosskliniken AG reported an EPS of €11.301 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 16.279%.

Which hedge fund is a major shareholder of Limes Schlosskliniken AG?

Currently, no hedge funds are holding shares in DE:LIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Limes Schlosskliniken AG Stock Smart Score

Outperform

Insider Transactions

Bought Shares

Worth €69.9K over
the Last 3 Months

Technicals

Fundamentals

Return on Equity

23.66%

Trailing 12-Months

Asset Growth

30.89%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Limes Schlosskliniken AG

LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of GMF Capital Gmbh.